Jump to content
RemedySpot.com

Dozen Stanford physicians under fire for speaking at gigs paid for by drugmakers

Rate this topic


Recommended Posts

Posted

http://www.mercurynews.com/peninsula/ci_16906586?source=rss & nclick_check=1

Dozen Stanford physicians under fire for speaking at gigs paid for by drugmakers

By M. Krieger

lkrieger@...

A dozen physicians at Stanford University's School of Medicine are under

investigation by the school's disciplinary board for their too-cozy

relationships with drug companies.

These physicians delivered speeches paid for by drug companies, in violation of

school policy, according to a public database reported by the non-profit online

investigative new website ProPublica.

" A review is under way, " said Stanford School of Medicine dean Dr. Phil Pizzo,

who in 2009 created a policy prohibiting such behavior among the university's

1,500 physicians.

" They now recognize what they did was wrong, " he said. " If we find someone who

continues to violate policy, we will consider disciplinary action. "

Violators include Dr. Alan Yeung, Stanford's chief of cardiovascular medicine,

who was paid $53,000 from Eli Lilly & Co. to speak at a " Healthcare Professional

Education Program " in an appearance that included another $1,463 for travel and

a $375 consulting fee. He reportedly quit speaking for the company last fall.

Also named in the ProPublica reporting was child psychiatrist Hans Steiner, now

retired, who was paid $109,000 by Eli Lilly to talk about Strattera, a drug that

treat's attention deficit hyperactivity disorder. In a response to the

ProPublica report, he said he assumed the policy didn't apply to him once he

became an emeritus professor, but he will now comply.

Among other named physicians are neurologist ph Lacy, paid $1,300 by Glaxo

Kline and urologist Rodney paid $5,000, also by the same company.

They were among 17,000 doctors nationwide who were paid a total of $257.8

million by seven companies in 2009 and the first two quarters of 2010, according

the a ProPublica database. In California, about 3,000 doctors received an

estimated $28.6 million in payments from pharmaceutical companies for speeches

promoting brand-label drugs to fellow doctors, the report said.

" The vast majority (of Stanford faculty) are paying attention to our

guidelines, " said Pizzo.

The violators have been referred to the senior associate dean for academic

affairs at the medical school.

Many Stanford physicians are paid consulting fees by drug companies, which are

disclosed to the university and not prohibited, because they improve companies'

ability to design and test drugs, ultimately helping human health. For instance,

Kiki Chang, director of the Pediatric Bipolar Disorder Program, was paid $5,936

to consult for Eli Lilly; oncologist Carlson was paid $4,665 to consult

for Pfizer.

The Mercury News tried to contact some Stanford doctors, but calls were not

returned by deadline.

The names of doctors moonlighting for drug makers were private until last year.

So far, seven drug makers have started disclosing payments. All will be required

to disclose the information by 2013 as part of the Physician Payments Sunshine

Act.

The practice is legal, but it creates the perception of conflict-of-interest

because doctors promote certain drugs to their peers and get paid by the drug

companies to do it.

Drug companies say the practice is designed to better serve patients by

educating doctors about illnesses and the drugs available to combat them. But

there is widespread concern that the payments may induce doctors to advocate for

the companies' brand-name drugs, rather than lesser priced generic alternatives.

Stanford's Pizzo first issued guidelines governing physician behavior in 2006,

and clarified them in 2009. These policies have been publicized 17 times in the

dean's online newsletter.

When alerted to the ProPublica database, Pizzo conducted a preliminary

investigation, which suggested that " some individuals ... had understandable

reasons for confusion. Others, though, offered explanations why their activities

continued that are difficult if not impossible to reconcile with our policy, and

here we have concerns, " said Pizzo.

" This is unacceptable, certainly for anyone with a Stanford title, " he said.

Stanford's medical community is large and diverse, with 1,500 physicians playing

different roles, Pizzo said. There are decade-long relationships with drug

companies that " don't unravel with the stroke of a pen. They take time. "

Moreover, the school must rely on the honor system for compliance. It does not

inspect personal tax returns, for instance.

" At the end of the day, we are involved in a trusting relationship with our

faculty. And we expect them to be straight and honest with us in their

disclosures, " said Pizzo. " We count on an honest interpretation by them of what

we do. "

Posted

http://www.mercurynews.com/peninsula/ci_16906586?source=rss & nclick_check=1

Dozen Stanford physicians under fire for speaking at gigs paid for by drugmakers

By M. Krieger

lkrieger@...

A dozen physicians at Stanford University's School of Medicine are under

investigation by the school's disciplinary board for their too-cozy

relationships with drug companies.

These physicians delivered speeches paid for by drug companies, in violation of

school policy, according to a public database reported by the non-profit online

investigative new website ProPublica.

" A review is under way, " said Stanford School of Medicine dean Dr. Phil Pizzo,

who in 2009 created a policy prohibiting such behavior among the university's

1,500 physicians.

" They now recognize what they did was wrong, " he said. " If we find someone who

continues to violate policy, we will consider disciplinary action. "

Violators include Dr. Alan Yeung, Stanford's chief of cardiovascular medicine,

who was paid $53,000 from Eli Lilly & Co. to speak at a " Healthcare Professional

Education Program " in an appearance that included another $1,463 for travel and

a $375 consulting fee. He reportedly quit speaking for the company last fall.

Also named in the ProPublica reporting was child psychiatrist Hans Steiner, now

retired, who was paid $109,000 by Eli Lilly to talk about Strattera, a drug that

treat's attention deficit hyperactivity disorder. In a response to the

ProPublica report, he said he assumed the policy didn't apply to him once he

became an emeritus professor, but he will now comply.

Among other named physicians are neurologist ph Lacy, paid $1,300 by Glaxo

Kline and urologist Rodney paid $5,000, also by the same company.

They were among 17,000 doctors nationwide who were paid a total of $257.8

million by seven companies in 2009 and the first two quarters of 2010, according

the a ProPublica database. In California, about 3,000 doctors received an

estimated $28.6 million in payments from pharmaceutical companies for speeches

promoting brand-label drugs to fellow doctors, the report said.

" The vast majority (of Stanford faculty) are paying attention to our

guidelines, " said Pizzo.

The violators have been referred to the senior associate dean for academic

affairs at the medical school.

Many Stanford physicians are paid consulting fees by drug companies, which are

disclosed to the university and not prohibited, because they improve companies'

ability to design and test drugs, ultimately helping human health. For instance,

Kiki Chang, director of the Pediatric Bipolar Disorder Program, was paid $5,936

to consult for Eli Lilly; oncologist Carlson was paid $4,665 to consult

for Pfizer.

The Mercury News tried to contact some Stanford doctors, but calls were not

returned by deadline.

The names of doctors moonlighting for drug makers were private until last year.

So far, seven drug makers have started disclosing payments. All will be required

to disclose the information by 2013 as part of the Physician Payments Sunshine

Act.

The practice is legal, but it creates the perception of conflict-of-interest

because doctors promote certain drugs to their peers and get paid by the drug

companies to do it.

Drug companies say the practice is designed to better serve patients by

educating doctors about illnesses and the drugs available to combat them. But

there is widespread concern that the payments may induce doctors to advocate for

the companies' brand-name drugs, rather than lesser priced generic alternatives.

Stanford's Pizzo first issued guidelines governing physician behavior in 2006,

and clarified them in 2009. These policies have been publicized 17 times in the

dean's online newsletter.

When alerted to the ProPublica database, Pizzo conducted a preliminary

investigation, which suggested that " some individuals ... had understandable

reasons for confusion. Others, though, offered explanations why their activities

continued that are difficult if not impossible to reconcile with our policy, and

here we have concerns, " said Pizzo.

" This is unacceptable, certainly for anyone with a Stanford title, " he said.

Stanford's medical community is large and diverse, with 1,500 physicians playing

different roles, Pizzo said. There are decade-long relationships with drug

companies that " don't unravel with the stroke of a pen. They take time. "

Moreover, the school must rely on the honor system for compliance. It does not

inspect personal tax returns, for instance.

" At the end of the day, we are involved in a trusting relationship with our

faculty. And we expect them to be straight and honest with us in their

disclosures, " said Pizzo. " We count on an honest interpretation by them of what

we do. "

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...